Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: Underlying mechanisms and therapy perspectives

American Journal of Clinical Nutrition

Volumn 71, Issue 5, 2000, Pages 1033-1047

  Gosker, Harry R ^a,b   Wouters, Emiel F M ^a   Van Der Vusse, Ger J ^a   Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anabolic steroids; Antioxidant status; CHF; Chronic heart failure; Chronic obstructive pulmonary disease; COPD; Disuse; Exercise intolerance; Hypoxia; Medication; Muscle metabolism; Muscle morphology; Muscle performance; Nutritional depletion; Nutritional support; Oxidative stress; Oxygen therapy; Peripheral muscle; Respiratory muscle; Review; Skeletal muscle; Systemic inflammation; Training

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; 6 PHOSPHOFRUCTOKINASE; ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANABOLIC AGENT; ANTIINFLAMMATORY AGENT; ASCORBIC ACID; CITRATE SYNTHASE; CORTICOSTEROID; CREATINE PHOSPHATE; CYTOCHROME C OXIDASE; FISH OIL; GLUCOSE; GLUTATHIONE; GLYCOGEN; HEXOKINASE; HUMAN GROWTH HORMONE; INOSINE PHOSPHATE; LACTATE DEHYDROGENASE; LACTIC ACID; MUSCLE ENZYME; PREDNISONE; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; VITAMIN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG USE; ENDURANCE; ENZYME ACTIVITY; EXERCISE; EXERCISE TOLERANCE; FAST MUSCLE FIBER; HEART FAILURE; HYPOXIA; INFLAMMATION; METABOLITE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCLE TRAINING; MYOPATHY; NUTRITION; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; OXYGEN THERAPY; REVIEW;

EID: 0034097322     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/71.5.1033     Document Type: Review

References (236)

1. Wood PH. Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron 1980;34:376-80.
2. Cotes JE, Zejda J, King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis 1988;137:1089-93.
3. Schols AM, Mostert R, Soeters PB, Wouters EF. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991;46:695-9.
4. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
5. Steele IC, Moore A, Nugent AM, Riley MS, Campbell NPS, Nicholls DP. Non-invasive measurement of cardiac output and ventricular ejection fractions in chronic cardiac failure: relationship to impaired exercise tolerance. Clin Sci 1997;93:195-203.
6. Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 1995;38:1-22.
7. Senior RM, Anthonisen NR. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 1998;157:S139-47.
8. Miller MM. Current trends in the primary care management of chronic congestive heart failure. Nurse Pract 1994;19:64-70.
9. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-420.
10. Grover FL, Fullerton DA. Zamora MR, et al. The past, present, and future of lung transplantation. Am J Surg 1997;173:523-33.
11. Beller GA. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation. J Nucl Cardiol 1997;4:S152-7.
12. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998;351:24-7.
13. Williams TJ, Snell GI. Early and long-term functional outcomes in unilateral, bilateral, and living-related transplant recipients. Clin Chest Med 1997;18:245-57.
14. Stratton JR, Kemp GJ, Daly RC, Yacoub M, Rajagopalan B. Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure. Circulation 1994;89:1624-31.
15. Armstrong RB. Muscle fiber recruitment patterns and their metabolic correlates. In: Horton HS, Terjung RL, eds. Exercise, nutrition, and energy metabolism. New York: Macmillan Publishing Company, 1988:9-26.
16. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997;10:417-23.
17. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
18. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
19. Zattara-Hartmann MC, Badier M, Guillot C, Tomei C, Jammes Y. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 1995;18:495-502.
20. Chua TP, Anker SD, Harrington D, Coats AJ. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br Heart J 1995;74:381-5.
21. McParland C, Resch EF, Krishnan B, Wang Y, Cujec B, Gallagher CG. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 1995;151:1101-7.
22. Lands LC, Heigenhauser GJ, Jones NL. Respiratory and peripheral muscle function in cystic fibrosis. Am Rev Respir Dis 1993; 147:865-9.
23. Harrington D, Anker SD. Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30:1758-64.
24. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-40.
25. Lipkin DP, Jones DA, Round JM, Poole Wilson PA. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988;18:187-95.
26. Karlsson J, Diamant B, Folkers K. Exercise-limiting factors in respiratory distress. Respiration 1992;2:18-23.
27. Belman MJ. Exercise in patients with chronic obstructive pulmonary disease. Thorax 1993;48:936-46.
28. Myers J, Salleh A, Buchanan N, et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 1992;124:710-9.
29. Drexler H. Changes in the peripheral circulation in heart failure. Curr Opin Cardiol 1995;10:268-73.
30. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-93.
31. Engelen MPKJ, Schols AMWJ, Does JD, Wouters EFM. Exercise induced lactate increase in relation to physical activity level and peripheral muscle substrates in COPD. Am J Respir Crit Care Med 1999;159:A475 (abstr).
32. Maltais F, Jobin J, Sullivan MJ, et al. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol 1999;84:1573-80.
33. Mainwood GW, Renaud JM. The effect of acid-base balance on fatigue of skeletal muscle. Can J Physiol Pharmacol 1985;63:403-16.
34. Morrison NJ, Richardson J, Dunn L, Pardy RL. Respiratory muscle performance in normal elderly subjects and patients with COPD. Chest 1989;95:90-4.
35. Decramer M, Aubier M. The respiratory muscles: cellular and molecular physiology. Eur Respir J 1997;10:1943-5.
36. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991;325:917-23.
37. Pardy RL, Rivington RN, Despas PJ, Macklem PT. The effects of inspiratory muscle training on exercise performance in chronic airflow limitation. Am Rev Respir Dis 1981;123:426-33.
38. Fitting JW. Respiratory muscle fatigue limiting physical exercise? Eur Respir J 1991;4:103-8.
39. Engelen MP, Casaburi R, Rucker R, Carithers E. Contribution of the respiratory muscles to the lactic acidosis of heavy exercise in COPD. Chest 1995;108:1246-51.
40. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993;148:1351-7.
41. Mancini DM, Henson D, LaManca J, Levine S. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992;86:909-18.
42. Wilson JR, Mancini DM. The mechanism of extertional fatigue in heart failure. Cardioscience 1990;1:13-7.
43. Shephard RJ. Exercise for patients with congestive heart failure. Sports Med 1997;23:75-92.
44. Miyagi K, Asanoi H, Ishizaka S, et al. Importance of total leg muscle mass for exercise intolerance in chronic heart failure. Jpn Heart J 1994;35:15-26.
45. Engelen MP, Schols AM, Baken WC, Wesseling GJ, Wouters EF. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7:1793-7.
46. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-74.
47. Wuyam B, Payen JF, Levy P, et al. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 1992;5:157-62.
48. Rochester DF. Body weight and respiratory muscle function in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134:646-8.
49. Morrison WL, Gibson JN, Scrimgeour C, Rennie MJ. Muscle wasting in emphysema. Clin Sci 1988;75:415-20.
50. Sato Y, Asoh T, Honda Y, Fujimatsu Y, Higuchi I, Oizumi K. Morphologic and histochetnical evaluation of muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur Neurol 1997;37:116-21.
51. Gertz I, Hedenstierna G, Hellers G, Wahren J. Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. Clin Sci Mol Med 1977;52:395-403.
52. Dunnigan A, Staley NA, Smith SA, et al. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol 1987;10:608-18.
53. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990;81:518-27.
54. Schaufelberger M, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle fiber composition and capillarization in patients with chronic heart failure: relation to exercise capacity and central hemodynamics. J Card Fail 1995;1:267-72.
55. 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989;80:1338-46.
56. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85:1751-9.
57. Lampert E, Mettauer B, Hoppeler H, Charloux A, Charpentier A, Lonsdorfer J. Structure of skeletal muscle in heart transplant recipients. J Am Coll Cardiol 1996;28:980-4.
58. Hambrecht R, Fiehn E, Yu J, et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997;29:1067-73.
59. McComas AJ. Skeletal muscle: form and function. Champaign, IL: Human Kinetics, 1996.
60. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996;76:371-423.
61. Pereira Sant'Ana JA, Ennion S, Sargeant AJ, et al. Comparison of the molecular, antigenic and ATPase determinants of fast myosin heavy chains in rat and human: a single-fibre study. Pflügers Arch 1997;435:151-63.
62. Harridge SDR, Bottinelli R, Canepari M, et al. Whole-muscle and single-fibre contractile properties and myosin heavy chain isoforms in humans. Pflügers Arch 1996;432:913-20.
63. Satta A, Migliori GB, Spanevello A, et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10:2853-60.
64. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990;3:192-6.
65. Maltais F, Sullivan MJ, LeBlanc P, et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999;13:850-4.
66. Hildebrand IL, Sylvén C, Esbjörnsson M, Hellström K, Jansson E. Does chronic hypoxaemia induce transformations of fibre types? Acta Physiol Scand 1991;141:435-9.
67. Sullivan MJ, Duscha BD, Klitgaard H. Kraus WE, Cobb FR, Saltin B. Altered expression of myosin heavy chain in human skeletal muscle in chronic heart failure. Med Sci Sports Exerc 1997;29:860-6.
68. Mizuno M. Human respiratory muscles: fibre morphology and capillary supply. Eur Respir J 1991;4:587-601.
69. Lindsay DC, Lovegrove CA, Dunn MJ, et al. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 1996;17:1239-50.
70. Tikunov B, Levine S, Mancini D. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation 1997;95:910-6.
71. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997;337:1799-806.
72. Morton JM, McKenna MJ, Carey MF, et al. Skeletal muscle pathophysiology in subjects with severe COAD. In: The Thoracic Society of Australia & New Zealand 1998 annual scientific meeting "Frontiers of Respiratory Medicine" program and abstracts book. Adelaide. Australia: Thoracic Society of Australia & New Zealand, 1998:012 (abstr).
73. Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW. Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. Respiration 1983; 44:321-8.
74. Hards JM, Reid WD, Pardy RL, Pare PD. Respiratory muscle fiber morphometry. Correlation with pulmonary function and nutrition. Chest 1990;97:1037-44.
75. Campbell JA, Hughes RL, Sahgal V, Frederiksen J, Shields TW. Alterations in intercostal muscle morphology and biochemistry in patients with obstructive lung disease. Am Rev Respir Dis 1980;122:679-86.
76. Gea JG. Myosin gene expression in the respiratory muscles. Eur Respir J 1997;10:2404-10.
77. Harridge SD, Magnusson G, Gordon A. Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. Eur Heart J 1996;17:896-901.
78. Fiaccadori E, Del Canale S, Vitali P, Coffrini E, Ronda N, Guariglia A. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest 1987;92:883-7.
79. Broqvist M, Arnqvisi H, Dahlström U, Larsson J, Nylander E, Permert J. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - effects of long-term dietary supplementation. Eur Heart J 1994;15:1641-50.
80. Opasich C, Aquilani R, Dossena M, et al. Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure. Eur Heart J 1996;17:1686-93.
81. Pouw EM, Schols AMWJ, Vusse van der GJ, Wouters EFM. Elevated inosine monophosphate levels in resting muscle of patients with stable COPD. Am J Respir Crit Care Med 1998;157:453-57.
82. Schaufelberger M, Eriksson BO, Held P, Swedberg K. Skeletal muscle metabolism during exercise in patients with chronic heart failure. Heart 1996;76:29-34.
83. Dudley GA, Terjung RL. Influence of aerobic metabolism on IMP accumulation in fast-twitch muscle. Am J Physiol 1985;248:C37-42.
84. Thompson CH, Davies RJ, Kemp GJ, Taylor DJ, Radda GK, Rajagopalan B. Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure. Thorax 1993;48:486-90.
85. Payen JF, Wuyam B, Levy P, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis 1993;147:592-8.
86. Mancini DM, Walter G, Reichek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364-73.
87. Kemp GJ, Thompson CH, Stratton JR, et al. Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis. Heart 1996;76:35-41.
88. 31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment. Am Rev Respir Dis 1992;146:1019-24.
89. 31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur Respir J 1992;5:163-9.
90. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:374-7.
91. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 1991;84:1597-607.
92. Sánchez, J, Brunet A, Medrano G, Debesse B, Derenne JP. Metabolic enzymatic activities in the intercostal and serratus muscles and in the latissimus dorsi of middle-aged normal men and patients with moderate obstructive pulmonary disease. Eur Respir J 1988;1:376-83.
93. Sauleda J, García-Palmer F, Wiesner RJ, et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1413-7.
94. Sánchez J, Bastien C, Medrano G, Riquet M, Derenne JP. Metabolic enzymatic activities in the diaphragm of normal men and patients with moderate chronic obstructive pulmonary disease. Bull Eur Physiopathol Respir 1984;20:535-40.
95. Essén-Gustavsson B, Henriksson J. Enzyme levels in pools of microdissected human muscle fibres of identified type. Adaptive response to exercise. Acta Physiol Scand 1984;120:505-15.
96. Stryer L. Biochemistry. New York: WH Freeman and Company, 1988.
97. Tein I. Metabolic myopathies. Semin Pediatr Neurol 1996;3:59-98.
98. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 1998;201:1129-39.
99. Hoppeler H, Kleinert E, Schlegel C, et al. Morphological adaptations of human skeletal muscle to chronic hypoxia. Int J Sports Med 1990;11:S3-9.
100. Hoppeler H, Desplanches D. Muscle structural modifications in hypoxia. Int J Sports Med 1992;13:S166-8.
101. Howald H, Pette D, Simoneau JA, Uber A, Hoppeler H, Cerretelli P. Effects of chronic hypoxia on muscle enzyme activities. Int J Sports Med 1990;11:S10-4.
102. Melissa L, MacDougall JD, Tarnopolsky MA, Cipriano N, Green HJ. Skeletal muscle adaptations to training under normobaric hypoxic versus normoxic conditions. Med Sci Sports Exerc 1997;29:238-43.
103. Bigard AX, Brunet A. Guezennec CY, Monod H. Effects of chronic hypoxia and endurance training on muscle capillarity in rats. Pflügers Arch 1991;419:225-9.
104. Ekeren van GJ, Sengers RC, Stadhouders AM. Changes in volume densities and distribution of mitochondria in rat skeletal muscle after chronic hypoxia. Int J Exp Pathol 1992;73:51-60.
105. Snyder GK, Farrelly C, Coelho JR. Adaptations in skeletal muscle capillarity following changes in oxygen supply and changes in oxygen demands. Eur J Appl Physiol 1992;65:158-63.
106. Preedy VR, Smith DM, Sugden PH. The effects of 6 hours of hypoxia on protein synthesis in rat tissues in vivo and in vitro. Biochem J 1985;228:179-85.
107. Fuller SJ, Sugden PH. Acute inhibition of rat heart protein synthesis in vitro during beta-adrenergic stimulation or hypoxia. Am J Physiol 1988;255:E537-47.
108. Milley JR. Protein synthesis during hypoxia in fetal lambs. Am J Physiol 1987;252:E519-24.
109. Kwast KE, Hand SC. Acute depression of mitochondrial protein synthesis during anoxia: contributions of oxygen sensing, matrix acidification, and redox state. J Biol Chem 1996;271:7313-9.
110. Ishihara A, Itoh K, Oishi Y, Itoh M, Hirofuji C, Hayashi H. Effects of hypobaric hypoxia on histochemical fibre-type composition and myosin heavy chain isoform component in the rat soleus muscle. Pflügers Arch 1995;429:601-6.
111. Itoh K, Itoh M, Ishihara A, Hirofuji C, Hayashi H. Influence of 12 weeks of hypobaric hypoxia on fibre type composition of the rat soleus muscle. Acta Physiol Scand 1995;154:417-8.
112. Taguchi S, Hata Y, Itoh K. Enzymatic responses and adaptations to swimming training and hypobaric hypoxia in postnatal rats. Jpn J Physiol 1985;35:1023-32.
113. Takahashi H, Kikuchi K, Nakayama H. Effect of chronic hypoxia on skeletal muscle fiber type in adult male rats. Ann Physiol Anthropol 1992;11:625-30.
114. Pastoris O, Dossena M, Foppa P, et al. Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism. Neurochem Res 1995;20:143-50.
115. Pastoris O, Gorini A, Vercesi L, Taglietti M, Dossena M. Modification of the skeletal muscle energy metabolism induced by intermittent normobaric hypoxia and treatment with biological pyrimidines. Farmaco [Sci] 1985;40:442-53.
116. Takahashi H, Kikuchi K, Nakayama H. Effect of chronic hypoxia on oxidative enzyme activity in rat skeletal muscle. Ann Physiol Anthropol 1993;12:363-9.
117. Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991;70:1593-600.
118. Xia Y, Warshaw JB, Haddad GG. Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult rats. Am J Physiol 1997;273:R1734-41.
119. Bashan N, Burdett E, Guma A, et al. Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 1993;264:C430-40.
120. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996;154:1055-60.
121. Keith M, Geranmayegan A. Sole MJ, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-6.
122. Giuliani A. Cestaro B. Exercise, free radical generation and vitamins. Eur J Cancer Prev 1997;6:S55-67.
123. Ji LL. Exercise, oxidative stress, and antioxidants. Am J Sports Med 1996;24:S20-4.
124. Reid MB. Reactive oxygen and nitric oxide in skeletal muscle. News Physiol Sci 1996;11:114-9.
125. Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 1996;15:1753-65.
126. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996;153:633-7.
127. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51:819-24.
128. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150:1453-5.
129. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-86.
130. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994;90:12-6.
131. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
132. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
133. Anker SD, Clark AL, Kemp M, et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 1997;30:997-1001.
134. Clarkson PM. Antioxidants and physical performance. Crit Rev Food Sci Nutr 1995;35:131-41.
135. Sen CK, Hänninen O. Physiological antioxidants. In: Sen KC, Packer L, Hänninen O, eds. Exercise and oxygen toxicity. Amsterdam: Elsevier Science BV, 1994:89-126.
136. Ohishi S, Kizaki T, Nagasawa J, et al. Effects of endurance training on superoxide dismutase activity, content and mRNA expression in rat muscle. Clin Exp Pharmacol Physiol 1997;24:326-32.
137. Jackson MJ. Exercise and oxygen radical production by muscle. In: Sen KC, Packer L, Hänninen O, eds. Exercise and oxygen toxicity. Amsterdam: Elsevier Science BV, 1994:49-57.
138. Ferrari R, Ceconi C, Curello S, Alfieri O, Visioli O. Myocardial damage during ischaemia and reperfusion. Eur Heart J 1993;14:25-30.
139. Liu J, Simon LM, Phillips JR, Robin ED. Superoxide dismutase (SOD) activity in hypoxic mammalian systems. J Appl Physiol 1977; 42:107-10.
140. Li RK, Mickle DA, Weisel RD. et al. Effect of oxygen tension on the anti-oxidant enzyme activities of tetralogy of Fallot ventricular myocytes. J Mol Cell Cardiol 1989;21:567-75.
141. Gardner TJ. Oxygen radicals and myocardial stunning. J Card Surg 1994;9:422-4.
142. Smith DR, Stone D, Darley-Usmar VM. Stimulation of mitochondrial oxygen consumption in isolated cardiomyocytes after hypoxiareoxygenation. Free Radic Res 1996;24:159-66.
143. Haramaki N, Packer L. Oxidative stress indices in exercise. In: Sen KC, Packer L, Hanninen O. eds. Exercise and oxygen toxicity. Amsterdam: Elsevier Science BV, 1994:77-87.
144. Salganik RI, Shabalina IG, Solovyova NA, Kolosova NG, Solovyov VN, Kolpakov AR. Impairment of respiratory functions in mitochondria of rats with an inherited hyperproduction of free radicals. Biochem Biophys Res Commun 1994;205:180-5.
145. Spragg RG, Hinshaw DB, Hyslop PA, Schraufstätter IU, Cochrane CG. Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury. J Clin Invest 1985;76:1471-6.
146. Astier C, Rock E, Lab C, Gueux E, Mazur A, Rayssiguier Y. Functional alterations in sarcoplasmic reticulum membranes of magnesium-deficient rat skeletal muscle as consequences of free radical-mediated process. Free Radic Biol Med 1996;20:667-74.
147. Wang SY, Clague JR, Langer GA. Increase in calcium leak channel activity by metabolic inhibition or hydrogen peroxide in rat ventricular myocytes and its inhibition by polycation. J Mol Cell Cardiol 1995;27:211-22.
148. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 1997;80:76-81.
149. Minezaki KK. Suleiman MS, Chapman RA. Changes in mitochondrial function induced in isolated guinea-pig ventricular myocytes by calcium overload. J Physiol (Lond) 1994;476:459-71.
150. Dean RT, Fu SL, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997;324:1-18.
151. Nagasawa T, Hatayama T, Watanabe Y, Tanaka M, Niisato Y, Kitts DD. Free radical mediated effects on skeletal muscle protein in rats treated with fe nitrilotriacetate. Biochem Biophys Res Commun 1997;231:37-41.
152. 2+ accumulation for the development of immobilization atrophy. Int J Sports Med 1993;14:437-9.
153. Thomas PK, Cooper JM, King RH, et al. Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function. J Anat 1993;183:451-61.
154. Haycock JW, Jones P. Harris JB, Mantle D. Differential susceptibility of human skeletal muscle proteins to free radical induced oxidative damage: a histochemical, immunocytochemical and electron microscopical study in vitro. Acta Neuropathol (Berl) 1996;92:331-40.
155. 2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol 1996;55:36-43.
156. Berg HE, Tesch PA. Changes in muscle function in response to 10 days of lower limb unloading in humans. Acta Physiol Scand 1996; 157:63-70.
157. Terjung RL, Dudley GA, Meyer RA. Metabolic and circulatory limitations to muscular performance at the organ level. J Exp Biol 1985;115:307-18.
158. Henriksson J, Reitman JS. Time course of changes in human skeletal muscle succinate dehydrogenase and cytochrome oxidase activities and maximal oxygen uptake with physical activity and inactivity. Acta Physiol Scand 1977;99:91-7.
159. Messner-Pellenc P, Brasileiro C, Ahmaidi S, et al. Exercise intolerance in patients with chronic heart failure: role of pulmonary diffusing limitation. Eur Heart J 1995;16:201-9.
160. Balkom van RH, Heijden van der HF, Herwaarden van CL, Dekhuijzen PN. Corticosteroid-induced myopathy of the respiratory muscles. Neth J Med 1994;45:114-22.
161. LaPier TK. Glucocorticoid-induced muscle atrophy. The rule of exercise in treatment and prevention. J Cardiopulm Rehabil 1997; 17:76-84.
162. Mayer M, Rosen F. Interaction of glucocorticoids and androgens with skeletal muscle. Metabolism 1977;26:937-62.
163. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1994;150:11-6.
164. Decramer M, de Bock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:1958-64.
165. Dekhuijzen PN, van Balkom RH. Steroid-induced change in the respiratory muscles: its relevance in patients with obstructive airways disease. Respir Med 1994;88:335-41.
166. Kamischke A, Kemper DE, Castel MA, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998;11:41-5.
167. Dekhuijzen PN, Decramer M. Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. Eur Respir J 1992;5:997-1003.
168. Wang YM, Zintel T, Vasquez A, Gallagher CG. Corticosteroid therapy and respiratory muscle function in humans. Am Rev Respir Dis 1991;144:108-12.
169. Koerts-de Lang E, Hesselink MKC, Drost MR, van der Vusse GJ, Wouters EFM, Schols AMWJ. Enzyme activity of rat tibialis anterior muscle differs between treatment with triamcinolone and prednisolone and nutritional deprivation. Eur J Appl Physiol 1999; 79:274-9.
170. Balkom van RH, Dekhuijzen PN, Folgering HT, Veerkamp JH, Fransen JA, van Herwaarden CL. Effects of long-term low-dose methylprednisolone on rat diaphragm function and structure. Muscle Nerve 1997;20:983-90.
171. Gardiner PF, Montanaro G. Simpson DR, Edgerton VR. Effects of glucocorticoid treatment and food restriction on rat hindlimb muscles. Am J Physiol 1980;238:E124-30.
172. 31P-MRS. Am J Respir Crit Care Med 1997;155:615-21.
173. Gray-Donald K, Gibbons L, Shapiro SH, Martin JG. Effect of nutritional status on exercise performance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:1544-8.
174. Efthimiou J, Fleming J, Gomes C, Spiro SG. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1988;137: 1075-82.
175. Carr JG, Stevenson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:709-13.
176. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-6.
177. Vermeeren MAP, Schols A, Wouters EFM. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J 1997;10:2264-9.
178. Schols AMWJ, Creutzberg EC, Buurman WA, Campfield LA, Saris WHM, Wouters EFM. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1220-6.
179. Hunter AM, Carey MA, Larsh HW. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981;124:376-81.
180. Creutzberg EC, Schols AMWJ, Bothmer-Quaedvlieg FCM, Wouters EFM. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 1998;52:396-401.
181. Schols AMWJ, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991;54:983-7.
182. Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, Nicholls DP. Resting energy expenditure in chronic cardiac failure. Clin Sci (Colch) 1991;80:633-9.
183. Obisesan TO, Toth MJ, Donaldson K, et al. Energy expenditure and symptom severity in men with heart failure. Am J Cardiol 1996; 77:1250-2.
184. Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:549-54.
185. Donahoe M, Rogers RM, Wilson DO, Pennock BE. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;140:385-91.
186. Sridhar MK, Carter R, Lean ME, Banham SW. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty. Thorax 1994;49:781-5.
187. McLoughlin DM, Spargo E, Wassif WS, et al. Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol Berl 1998;95:632-40.
188. Russell DM, Prendergast PJ, Darby PL, Garfinkel PE, Whitwell J, Jeejeebhoy KN. A comparison between muscle function and body composition in anorexia nervosa: the effect of refeeding. Am J Clin Nutr 1983;38:229-37.
189. Rigaud D, Moukaddem M, Cohen B, Malon D, Reveillard V, Mignon M. Refeeding improves muscle performance without normalization of muscle mass and oxygen consumption in anorexia nervosa patients. Am J Clin Nutr 1997;65:1845-51.
190. Lindboe CF, Askevold F, Slettebo M. Changes in skeletal muscles of young women with anorexia nervosa. An enzyme histochemical study. Acta Neuropathol Berl 1982;56:299-302.
191. Essen B, Fohlin L, Thoren C, Saltin B. Skeletal muscle fibre types and sizes in anorexia nervosa patients. Clin Physiol 1981;1:395-403.
192. Sieck GC, Lewis MI, Blanco CE. Effects of undernutrition on diaphragm fiber size, SDH activity, and fatigue resistance. J Appl Physiol 1989;66:2196-205.
193. Russell DM, Atwood HL, Whittaker JS, et al. The effect of fasting and hypocaloric diets on the functional and metabolic characteristics of rat gastrocnemius muscle. Clin Sci 1984;67:185-94.
194. Mijan de la Torre A, Madapallimattam A, Cross A, Armstrong RL, Jeejeebhoy KN. Effect of fasting, hypocaloric feeding, and refeeding on the energetics of stimulated rat muscle as assessed by nuclear magnetic resonance spectroscopy. J Clin Invest 1993;92:114-21.
195. Aguilaniu B, Goldstein Shapses S, Pajon A, et al. Muscle protein degradation in severely malnourished patients with chronic obstructive pulmonary disease subject to short-term total parenteral nutrition. JPEN J Parenter Enteral Nutr 1992;16:248-54.
196. Goldstein SA, Thomashow BM, Kvetan V, Askanazi J, Kinney JM, Elwyn DH. Nitrogen and energy relationships in malnourished patients with emphysema. Am Rev Respir Dis 1988;138:636-44.
197. Pouw EM, Schols AM, Deutz NE, Wouters EF. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:797-801.
198. Argilés JM, López-Soriano J. Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care 1998;1:241-4.
199. Hill GL. Body composition research: implications for the practice of clinical nutrition. JPEN J Parenter Enteral Nutr 1992;16:197-218.
200. Serres I, Varray A, Vallet G, Micallef JP, Préfaut C. Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 1997;17:232-8.
201. O'Donnell DE, McGuire M, Samis L, Webb KA. General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am J Respir Crit Care Med 1998;157:1489-97.
202. Adamopoulos S, Coats AJ. Peripheral abnormalities in chronic heart failure. Postgrad Med J 1991;67:S74-80.
203. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
204. Smith K, Cook D, Guyatt GH, Madhavan J, Oxman AD. Respiratory muscle training in chronic airflow limitation: a meta-analysis. Am Rev Respir Dis 1992;145:533-9.
205. Rochester DF. The diaphragm in COPD. Better than expected, but not good enough. N Engl J Med 1991;325:961-2.
206. Belman MJ, Botnick WC, Nathan SD, Chon KH. Ventilatory load characteristics during ventilatory muscle training. Am J Respir Crit Care Med 1994;149:925-9.
207. Rogers RM, Donahoe M, Costantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis 1992;146:1511-7.
208. Whittaker JS, Ryan CF, Buckley PA, Road JD. The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients. Am Rev Respir Dis 1990;142:283-8.
209. Schols AM, Soeters PB. Mostert R, Pluymers RJ, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995;152:1268-74.
210. Fiaccadori E, Coffrini E, Ronda N, et al. A preliminary report on the effects of malnutrition on skeletal muscle composition in chronic obstructive pulmonary disease. In: Ferranti RD, Rampulla C, Fracchia C, Ambrosino N, eds. Nutrition and ventilatory function. Verona, Italy: Bi & Gi Publishers, 1992:77-85.
211. Creutzberg EC, Schols AMWJ, Weling-Scheepers CAPM, Wouters EFM. Functional effects of nutritional supplementation therapy incorporated in a pulmonary rehabilitation programme in depleted patients with COPD. Am J Respir Crit Care Med 1998;157:A258 (abstr).
212. Creutzberg EC, Schols AMWJ, Weling-Scheepers CAPM, Buurman WA, Wouters EFM. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:745-52.
213. Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997;155:542-8.
214. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996;12:S27-30.
215. Creutzberg EC, Schols AMWJ. Anabolic steroids. Curr Opin Clin Nutr Metab Care 1999;2:243-53.
216. Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 1998;114:19-28.
217. Suchner U, Rothkopf MM, Stanislaus G, Elwyn DH, Kvetan V, Askanazi J. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. Arch Intern Med 1990;150:1225-30.
218. Pape GS, Friedman M, Underwood LE, Clemmons DR. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 1991;99:1495-500.
219. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:1800-6.
220. Shapira Y, Glick B, Finsterbush A, Goldfarb A, Rosenmann E. Myopathological findings in thalassemia major. Eur Neurol 1990; 30:324-7.
221. Goldfarb AH, Sen CK. Antioxidant supplementation and the control of oxygen toxicity during exercise. In: Sen KC, Packer L, Hänninen O, eds. Exercise and oxygen toxicity. Amsterdam: Elsevier Science BV, 1994:163-89.
222. Novelli GP, Adembri C, Gandini E, et al. Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion. Am J Surg 1997;173:206-9.
223. Alessio HM, Goldfarb AH, Cao GH. Exercise induced oxidative stress before and after vitamin C supplementation. Int J Sport Nutr 1997;7:1-9.
224. Sen CK, Atalay M, Agren J, Laaksonen DE, Roy S, Hanninen O. Fish oil and vitamin E supplementation in oxidative stress at rest and after physical exercise. J Appl Physiol 1997;83:189-95.
225. Appell HJ, Duarte JAR, Soares JMC. Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy. Int J Sports Med 1997;18:157-60.
226. Paiva SA, Godoy I, Vannucchi H, Favaro RM, Geraldo RR, Campana AO. Assessment of vitamin A status in chronic obstructive pulmonary disease patients and healthy smokers. Am J Clin Nutr 1996;64:928-34.
227. Dow L, Tracey M, Villar A, et al. Does dietary intake of vitamins C and E influence lung function in older people? Am J Respir Crit Care Med 1996;154:1401-4.
228. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-8.
229. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-6.
230. O'Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997;155:530-5.
231. Woodcock AA, Geddes DM, Gross ER. Oxygen relieves breathlessness in "pink puffers". Lancet 1981;1:907-9.
232. Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL, Folgering HT. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J 1997;10: 1278-84.
233. Jakobsson P, Jorfeldl L. Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxaemia. Respir Med 1995;89:471-6.
234. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997;156:341-57.
235. Jackson RM. Pulmonary oxygen toxicity. Chest 1985;88:900-5.
236. Jenkinson SG. Oxygen toxicity. New Horiz 1993;1:504-11.